Fosun Tourism Group, the unit of billionaire Guo Guangchang’s drugs-to-insurance conglomerate that’s seeking to raise as much as $548 million in a Hong Kong IPO, expects to price the deal toward the bottom of a marketed range.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
